Largest Canadian Companies by Revenue — Health Care
Canadian companies ranked by trailing-twelve-month revenue on TSX and TSXV.
Updated September 23, 2026200 companiesTotal market cap $2237.9B
Showing 200 companies (CDRs hidden)
| Rank | Company | Symbol | Market Cap | P/E Ratio | Revenue (TTM) |
|---|---|---|---|---|---|
| 1 | Sanofi ADR | SNY:US | $101.8B | 23.0 | $48.9B |
| 2 | Amgen Inc | AMGN:US | $212.6B | 24.5 | $38.1B |
| 3 | Gilead Sciences Inc | GILD:US | $186.7B | - | $30.5B |
| 4 | Medline Inc. Class A Common Stock | MDLN:US | $43.0B | 40.0 | $29.9B |
| 5 | GE HealthCare Technologies Inc. | GEHC:US | $29.9B | 15.3 | $21.3B |
| 6 | Regeneron Pharmaceuticals Inc | REGN:US | $82.2B | 19.7 | $15.5B |
| 7 | Viatris Inc | VTRS:US | $19.6B | - | $14.7B |
| 8 | BrightSpring Health Services, Inc. Common Stock | BTSG:US | $11.2B | 50.5 | $14.4B |
| 9 | Henry Schein Inc | HSIC:US | $9.5B | 24.8 | $13.6B |
| 10 | Vertex Pharmaceuticals Inc | VRTX:US | $130.4B | 30.0 | $12.6B |
| 11 | Intuitive Surgical Inc | ISRG:US | $143.9B | 46.0 | $11.0B |
| 12 | Bausch Health Companies Inc | BHC:TO | $3.1B | - | $10.9B |
| 13 | Biogen Inc | BIIB:US | $33.3B | 40.0 | $10.0B |
| 14 | ICON PLC | ICLR:US | $12.9B | 261.1 | $8.3B |
| 15 | Medirom Healthcare Technologies Inc | MRM:US | $6M | 2.0 | $8.1B |
| 16 | Grifols SA ADR | GRFS:US | $5.0B | 9.7 | $7.4B |
| 17 | Agilent Technologies Inc | A:US | $43.3B | 29.7 | $7.4B |
| 18 | BeiGene, Ltd. | ONC:US | $41.6B | 65.8 | $6.1B |
| 19 | Incyte Corporation | INCY:US | $25.3B | 15.9 | $5.8B |
| 20 | Option Care Health Inc | OPCH:US | $3.6B | 18.1 | $5.7B |
| 21 | The Ensign Group Inc | ENSG:US | $10.3B | 27.6 | $5.5B |
| 22 | Bausch + Lomb Corp | BLCO:TO | $8.4B | - | $5.3B |
| 23 | argenx NV ADR | ARGX:US | $61.5B | 37.6 | $5.3B |
| 24 | DexCom Inc | DXCM:US | $33.8B | 35.4 | $5.0B |
| 25 | Alnylam Pharmaceuticals Inc | ALNY:US | $32.7B | 42.5 | $4.8B |
| 26 | Jazz Pharmaceuticals PLC | JAZZ:US | $15.6B | 16.5 | $4.6B |
| 27 | Alignment Healthcare LLC | ALHC:US | $1.7B | 43.8 | $4.6B |
| 28 | IDEXX Laboratories Inc | IDXX:US | $40.6B | 36.2 | $4.6B |
| 29 | Illumina Inc | ILMN:US | $37.4B | 46.3 | $4.5B |
| 30 | The Cooper Companies, Inc | COO:US | $10.5B | 19.0 | $4.2B |
| 31 | Align Technology Inc | ALGN:US | $10.4B | 25.5 | $4.1B |
| 32 | Genmab AS | GMAB:US | $21.7B | 27.7 | $4.1B |
| 33 | Astrana Health Inc | ASTH:US | $1.7B | 42.8 | $3.8B |
| 34 | Dentsply Sirona Inc | XRAY:US | $1.9B | - | $3.6B |
| 35 | Bruker Corporation | BRKR:US | $9.4B | - | $3.5B |
| 36 | Biomarin Pharmaceutical Inc | BMRN:US | $12.4B | 173.1 | $3.4B |
| 37 | Neurocrine Biosciences Inc | NBIX:US | $14.5B | 20.8 | $3.4B |
| 38 | Acadia Healthcare Company Inc | ACHC:US | $2.7B | - | $3.4B |
| 39 | Surgery Partners Inc | SGRY:US | $1.8B | - | $3.4B |
| 40 | Adapthealth Corp | AHCO:US | $785M | - | $3.4B |
| 41 | MiniMed Group, Inc. Common Stock | MMED:US | $5.9B | - | $3.2B |
| 42 | United Therapeutics Corporation | UTHR:US | $21.3B | 17.8 | $3.2B |
| 43 | Amneal Pharmaceuticals, Inc. Class A Common Stock | AMRX:US | $6.8B | 40.6 | $3.1B |
| 44 | Insulet Corporation | PODD:US | $9.7B | 26.2 | $3.1B |
| 45 | Medpace Holdings Inc | MEDP:US | $17.4B | 36.7 | $2.8B |
| 46 | Natera Inc | NTRA:US | $53.4B | - | $2.7B |
| 47 | Fortrea Holdings Inc. | FTRE:US | $1.9B | - | $2.7B |
| 48 | Quidel Corporation | QDEL:US | $745M | - | $2.7B |
| 49 | BioNTech SE | BNTX:US | $25.3B | - | $2.6B |
| 50 | Aveanna Healthcare Holdings Inc | AVAH:US | $2.9B | 10.7 | $2.6B |
| 51 | Royalty Pharma Plc | RPRX:US | $33.8B | 31.4 | $2.5B |
| 52 | Clover Health Investments Corp | CLOV:US | $2.4B | - | $2.5B |
| 53 | Exelixis Inc | EXEL:US | $14.4B | 18.3 | $2.4B |
| 54 | Privia Health Group Inc | PRVA:US | $2.5B | 88.8 | $2.4B |
| 55 | RadNet Inc | RDNT:US | $5.8B | - | $2.3B |
| 56 | Moderna Inc | MRNA:US | $72.9B | - | $2.2B |
| 57 | ICU Medical Inc | ICUI:US | $4.0B | 134.2 | $2.2B |
| 58 | Extendicare Inc | EXE:TO | $3.0B | 23.9 | $2.0B |
| 59 | Sarepta Therapeutics Inc | SRPT:US | $2.1B | - | $2.0B |
| 60 | Alkermes Plc | ALKS:US | $7.3B | 113.9 | $1.7B |
| 61 | Halozyme Therapeutics Inc | HALO:US | $12.6B | 32.7 | $1.7B |
| 62 | Integra LifeSciences Holdings | IART:US | $1.2B | - | $1.6B |
| 63 | Lifestance Health Group Inc | LFST:US | $4.8B | 97.5 | $1.6B |
| 64 | Merit Medical Systems Inc | MMSI:US | $5.2B | 35.9 | $1.6B |
| 65 | Lantheus Holdings Inc | LNTH:US | $6.5B | 24.0 | $1.6B |
| 66 | Phibro Animal Health Corporation | PAHC:US | $1.4B | 14.5 | $1.5B |
| 67 | WELL Health Technologies Corp | WELL:TO | $1.1B | 220.5 | $1.5B |
| 68 | P3 Health Partners Inc | PIII:US | $1.5B | - | $1.5B |
| 69 | Addus HomeCare Corporation | ADUS:US | $2.1B | 20.0 | $1.5B |
| 70 | LivaNova PLC | LIVN:US | $4.3B | 23.1 | $1.5B |
| 71 | Tempus AI, Inc. Class A Common Stock | TEM:US | $13.9B | - | $1.4B |
| 72 | HealthEquity Inc | HQY:US | $7.8B | 34.1 | $1.4B |
| 73 | Indivior PLC Ordinary Shares | INDV:US | $4.3B | 13.0 | $1.3B |
| 74 | Progyny Inc | PGNY:US | $2.0B | 28.5 | $1.3B |
| 75 | Madrigal Pharmaceuticals Inc | MDGL:US | $12.1B | - | $1.3B |
| 76 | Legend Biotech Corp | LEGN:US | $3.6B | - | $1.3B |
| 77 | Omnicell Inc | OMCL:US | $1.5B | 38.6 | $1.2B |
| 78 | Sotera Health Co | SHC:US | $5.3B | 32.8 | $1.2B |
| 79 | Bio-Techne Corp | TECH:US | $11.4B | 62.5 | $1.2B |
| 80 | Waystar Holding Corp. Common Stock | WAY:US | $4.9B | 36.6 | $1.2B |
| 81 | Guardant Health Inc | GH:US | $23.8B | - | $1.2B |
| 82 | ACADIA Pharmaceuticals Inc | ACAD:US | $4.6B | 11.8 | $1.1B |
| 83 | Insmed Inc | INSM:US | $26.4B | - | $1.1B |
| 84 | Pennant Group Inc | PNTG:US | $1.4B | 43.3 | $1.1B |
| 85 | Sienna Senior Living Inc | SIA:TO | $2.3B | 38.4 | $1.1B |
| 86 | Ascendis Pharma AS | ASND:US | $15.6B | 18.5 | $1.0B |
| 87 | Lumexa Imaging Holdings, Inc. Common Stock | LMRI:US | $1.0B | - | $1.0B |
| 88 | Tandem Diabetes Care Inc | TNDM:US | $1.2B | - | $1.0B |
| 89 | Embecta Corp | EMBC:US | $300M | 3.6 | $1.0B |
| 90 | PTC Therapeutics Inc | PTCT:US | $5.5B | - | $1.0B |
| 91 | Lakefront Biotherapeutics NV | LKFT:US | $1.9B | 2.9 | $991M |
| 92 | InnovAge Holding Corp | INNV:US | $1.5B | - | $990M |
| 93 | Caris Life Sciences, Inc. Common Stock | CAI:US | $8.7B | 3.2 | $990M |
| 94 | CorVel Corp | CRVL:US | $3.7B | 32.7 | $984M |
| 95 | ANI Pharmaceuticals Inc | ANIP:US | $1.8B | 17.0 | $978M |
| 96 | Harmony Biosciences Holdings | HRMY:US | $2.4B | 13.6 | $960M |
| 97 | BioCryst Pharmaceuticals Inc | BCRX:US | $2.2B | - | $941M |
| 98 | SNDL Inc. | SNDL:US | $347M | - | $928M |
| 99 | Tilray Inc | TLRY:US | $594M | - | $915M |
| 100 | Tilray Inc | TLRY:TO | $837M | - | $915M |
| 101 | Telix Pharmaceuticals Limited | TLX:US | $3.8B | 113.1 | $891M |
| 102 | Ionis Pharmaceuticals Inc | IONS:US | $7.5B | - | $874M |
| 103 | Neogen Corporation | NEOG:US | $3.0B | - | $870M |
| 104 | Varex Imaging Corp | VREX:US | $778M | 34.8 | $865M |
| 105 | Nutex Health Inc | NUTX:US | $1.4B | 7.8 | $847M |
| 106 | Kiniksa Pharmaceuticals Ltd | KNSA:US | $6.1B | 78.8 | $841M |
| 107 | Orthofix Medical Inc | OFIX:US | $363M | - | $833M |
| 108 | Corcept Therapeutics Incorporated | CORT:US | $12.7B | 255.4 | $831M |
| 109 | Supernus Pharmaceuticals Inc | SUPN:US | $2.5B | - | $830M |
| 110 | iRhythm Technologies Inc | IRTC:US | $3.6B | - | $825M |
| 111 | Alphatec Holdings Inc | ATEC:US | $1.6B | - | $815M |
| 112 | Collegium Pharmaceutical Inc | COLL:US | $714M | 18.1 | $808M |
| 113 | Myriad Genetics Inc | MYGN:US | $384M | - | $807M |
| 114 | TG Therapeutics Inc | TGTX:US | $8.9B | 21.2 | $800M |
| 115 | Goodrx Holdings Inc | GDRX:US | $1.2B | 57.3 | $785M |
| 116 | Repligen Corporation | RGEN:US | $10.5B | 259.4 | $785M |
| 117 | Axsome Therapeutics Inc | AXSM:US | $10.8B | - | $777M |
| 118 | NeoGenomics Inc | NEO:US | $2.4B | - | $766M |
| 119 | Pacira BioSciences, Inc. | PCRX:US | $985M | 70.6 | $746M |
| 120 | Amphastar P | AMPH:US | $1.0B | 14.5 | $730M |
| 121 | Evotec SE ADR | EVO:US | $547M | - | $717M |
| 122 | Ultragenyx | RARE:US | $1.5B | - | $717M |
| 123 | BridgeBio Pharma Inc | BBIO:US | $13.5B | - | $713M |
| 124 | Novocure Ltd | NVCR:US | $1.9B | - | $699M |
| 125 | Arrowhead Pharmaceuticals Inc | ARWR:US | $10.2B | - | $669M |
| 126 | TransMedics Group Inc | TMDX:US | $3.0B | 22.8 | $668M |
| 127 | Ascentage Pharma Group International | AAPG:US | $1.5B | - | $643M |
| 128 | UFP Technologies Inc | UFPT:US | $2.2B | 30.9 | $632M |
| 129 | Mirum Pharmaceuticals Inc | MIRM:US | $6.0B | - | $618M |
| 130 | 10X Genomics Inc | TXG:US | $10.5B | - | $617M |
| 131 | Azenta Inc | AZTA:US | $1.5B | - | $614M |
| 132 | Tarsus Pharmaceuticals Inc | TARS:US | $3.6B | - | $606M |
| 133 | Travere Therapeutics Inc | TVTX:US | $5.8B | - | $591M |
| 134 | Opko Health Inc | OPK:US | $1.3B | - | $588M |
| 135 | Bioventus Inc | BVS:US | $909M | 17.1 | $582M |
| 136 | AtriCure Inc | ATRC:US | $3.0B | 280.1 | $570M |
| 137 | Veracyte Inc | VCYT:US | $3.5B | 31.0 | $562M |
| 138 | Sucro Limited | SUGR:V | $228M | 4.1 | $561M |
| 139 | HUTCHMED DRC | HCM:US | $2.5B | 144.8 | $549M |
| 140 | ADMA Biologics Inc | ADMA:US | $2.2B | 14.0 | $512M |
| 141 | Sinovac Biotech Ltd | SVA:US | $642M | 6.7 | $511M |
| 142 | Burning Rock Biotech Ltd | BNR:US | $155M | - | $501M |
| 143 | Alvotech | ALVO:US | $2.1B | - | $495M |
| 144 | Arcutis Biotherapeutics Inc | ARQT:US | $3.3B | 118.0 | $464M |
| 145 | CorMedix Inc | CRMD:US | $606M | 3.6 | $462M |
| 146 | CareDx Inc | CDNA:US | $2.8B | 26.1 | $458M |
| 147 | Organogenesis Holdings Inc | ORGO:US | $190M | - | $457M |
| 148 | GeneDx Holdings Corp. | WGS:US | $2.7B | - | $454M |
| 149 | Liquidia Technologies Inc | LQDA:US | $6.1B | 49.0 | $451M |
| 150 | Ardelyx Inc | ARDX:US | $904M | - | $451M |
| 151 | Zai Lab Ltd | ZLAB:US | $3.0B | - | $450M |
| 152 | Krystal Biotech Inc | KRYS:US | $9.9B | 41.9 | $440M |
| 153 | Innoviva Inc | INVA:US | $1.5B | 4.9 | $440M |
| 154 | Twist Bioscience Corp | TWST:US | $10.9B | - | $432M |
| 155 | Immunocore Holdings Ltd | IMCR:US | $1.7B | - | $431M |
| 156 | Certara Inc | CERT:US | $1.3B | - | $422M |
| 157 | Novavax Inc | NVAX:US | $1.8B | - | $414M |
| 158 | Accuray Incorporated | ARAY:US | $27M | - | $402M |
| 159 | POMDOCTOR LIMITED American Depositary Shares | POM:US | $7M | - | $400M |
| 160 | MeiraGTx Holdings PLC | MGTX:US | $1.2B | 14.2 | $398M |
| 161 | BillionToOne, Inc. Class A Common Stock | BLLN:US | $4.9B | 146.3 | $397M |
| 162 | MannKind Corp | MNKD:US | $1.1B | - | $394M |
| 163 | Ironwood Pharmaceuticals Inc | IRWD:US | $729M | 5.6 | $389M |
| 164 | CareRx Corp | CRRX:TO | $201M | 7.5 | $377M |
| 165 | InMode Ltd | INMD:US | $832M | 11.9 | $375M |
| 166 | Pharming Group NV | PHAR:US | $765M | 77.2 | $366M |
| 167 | Castle Biosciences Inc | CSTL:US | $1.1B | - | $357M |
| 168 | MiMedx Group Inc | MDXG:US | $702M | 120.3 | $355M |
| 169 | Inogen Inc | INGN:US | $139M | - | $354M |
| 170 | Tactile Systems Technology Inc | TCMD:US | $518M | 21.4 | $350M |
| 171 | STAAR Surgical Company | STAA:US | $1.0B | 254.0 | $340M |
| 172 | Procept Biorobotics Corp | PRCT:US | $1.1B | - | $337M |
| 173 | Xeris Pharmaceuticals Inc | XERS:US | $1.6B | - | $335M |
| 174 | Amotiv Limited | AOV:TO | $577M | - | $332M |
| 175 | Iovance Biotherapeutics Inc | IOVA:US | $4.6B | - | $325M |
| 176 | Fulgent Genetics Inc | FLGT:US | $593M | - | $324M |
| 177 | HealthStream Inc | HSTM:US | $890M | 40.4 | $321M |
| 178 | AngioDynamics Inc | ANGO:US | $648M | - | $320M |
| 179 | Arvinas Inc | ARVN:US | $549M | 32.7 | $317M |
| 180 | Evolus Inc | EOLS:US | $545M | - | $316M |
| 181 | Aurora Cannabis Inc | ACB:US | $270M | - | $314M |
| 182 | Aurora Cannabis Inc | ACB:TO | $357M | - | $314M |
| 183 | Aurinia Pharmaceuticals Inc | AUPH:US | $2.2B | 7.3 | $312M |
| 184 | Omada Health, Inc. Common Stock | OMDA:US | $1.3B | 31.9 | $310M |
| 185 | OrganiGram Holdings Inc | OGI:US | $160M | 2.6 | $309M |
| 186 | OrganiGram Holdings Inc | OGI:TO | $226M | 2.6 | $309M |
| 187 | Adaptive Biotechnologies Corp | ADPT:US | $4.4B | - | $308M |
| 188 | Vericel Corp Ord | VCEL:US | $2.0B | 82.4 | $306M |
| 189 | Vir Biotechnology Inc | VIR:US | $1.8B | - | $303M |
| 190 | Viemed Healthcare Inc | VMD:US | $341M | 24.9 | $302M |
| 191 | DocGo Inc | DCGO:US | $36M | - | $295M |
| 192 | Canopy Growth Corp | WEED:TO | $584M | - | $294M |
| 193 | Canopy Growth Corp | CGC:US | $435M | - | $294M |
| 194 | Health Catalyst Inc | HCAT:US | $142M | - | $292M |
| 195 | Ligand Pharmaceuticals Incorporated | LGND:US | $5.8B | 29.8 | $291M |
| 196 | Protagonist Therapeutics Inc | PTGX:US | $9.4B | 140.8 | $282M |
| 197 | Kewaunee Scientific Corporation | KEQU:US | $99M | 12.4 | $277M |
| 198 | Rigel Pharmaceuticals Inc | RIGL:US | $912M | 2.9 | $277M |
| 199 | Harrow Health Inc | HROW:US | $1.3B | - | $276M |
| 200 | Medical Facilities Corporation | DR:TO | $244M | 11.7 | $265M |
Advertisement
Frequently Asked Questions
Which Canadian company ranks #1 by revenue (ttm) in Health Care?
As of September 23, 2026, Sanofi ADR (SNY:US) ranks #1 in Health Care at $48.9B.
How often is this ranking updated?
The table is rebuilt from live fundamentals throughout the day. This page currently shows data as of September 23, 2026.
How many companies are in this revenue (ttm) list?
This view shows 200 Canadian listings in Health Care. Canadian Depositary Receipts are hidden by default.
What is the difference between TSX and TSXV?
The Toronto Stock Exchange (TSX) lists larger established companies. The TSX Venture Exchange (TSXV) lists earlier-stage companies. Use the exchange filter to separate them.
Explore More Stock Rankings
Largest by Market Cap
Companies with the highest market capitalization
Highest Profit Margin
Most profitable companies by net margin
Highest Return on Equity
Companies generating the best returns for shareholders
Highest Return on Assets
Most efficient companies at using assets
Highest Dividend Yield
Top dividend-paying stocks
Fastest Revenue Growth
Companies with strongest year-over-year revenue growth
Fastest Earnings Growth
Companies with strongest year-over-year earnings growth